BioNTech

NEWS

Policy

Biopharma Update on the Novel Coronavirus: November 17

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 17, 2020.

November 16, 2020

6 min read

BioSpace Editorial Staff

Business

Can Pfizer’s COVID-19 Vaccine End the Pandemic? BioNTech’s CEO Believes So

The BioNTech scientist said his vaccine can “bash the virus over the head”.

November 13, 2020

2 min read

Kate Goodwin

Drug Development

Biopharma Update on the Novel Coronavirus: November 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 10, 2020.

November 9, 2020

4 min read

BioSpace Editorial Staff

Drug Development

Early Data Shows Pfizer and BioNTech’s COVID-19 Vaccine is 90% Effective

They caution that as more data is accumulated and analyzed, the efficacy percentage may shift. Nonetheless, it’s extremely promising and there were no serious safety signals.

November 9, 2020

3 min read

Mark Terry

Pharm Country

The Race for a COVID-19 Vaccine Continues to Heat Up as Case Numbers Rise

Several biopharmaceutical companies have made headway as of late in the race to develop a vaccine for COVID-19, which is responsible for the current global pandemic.

October 15, 2020

3 min read

Krystle Vermes

Policy

Regeneron, Pfizer and BioNTech Slapped with Patent Lawsuits for COVID-19 Therapies

Allele Biotechnology and Pharmaceuticals filed lawsuits claiming the companies infringed on Allele’s patented mNeonGreen technology in the development of their COVID-19 treatments.

October 6, 2020

2 min read

Alex Keown

Drug Development

COVID-19 Vaccine Update: Rolling Submissions in EU, Side Effects and Minority Enrollment

A few days ago, CNBC reported that five patients, three in Moderna’s and two in Pfizer’s Phase III trials, had experienced more severe, although transient side effects.

October 6, 2020

3 min read

Mark Terry